In Making Genetics we assume Research, Development and innovation as a fundamental pillar for all our activity. For this, we have an innovative strategy through the permanent introduction of new genomic and bioinformatic services to access new market segments. Specifically, since 2014 we have more than 9 lines of research funded.
Development and Clinical Validation of a system for the analysis of epigenetic biomarkers to personalize treatment in inflammatory and autoimmune diseases
Development and clinical validation of a system for the analysis of genetic and / or epigenetic biomarkers to personalize treatment in inflammatory and autoimmune diseases. Challenges Collaboration of the MINECO, a Torres Quevedo of the MINECO and a scholarship of technologists of the Government of Navarre. Cooperating with the Complutense University of Madrid, Hospital de la Princesa and three Spanish companies. Years of execution 2015-2018 and 2019-ongoing project.
DIgital Platform for Accurate Prognosis
This project has been carried out during 2021 together with the Nubba Innovation Group and has received funding from the DIGI-B-CUBE framework which has been supported by the European Union's Horizon 2020 research and innovation programme under grant agreement no. 824920.
Influence of microbiota diversity and composition on the development of paediatric fatty liver disease; Identification of biomarkers and development of personalised therapy: MicroKID project.
Grants for the execution of R&D projects in 2020 from the Government of Navarra. Years of execution 2020-2022. Cooperative with Navarrabiomed/Miguel Servet Foundation and Public University of Navarra.
Identification of biomarkers of non-alcoholic liver steatosis and risk of childhood type 2 diabetes mellitus
Aid for the realization of R&D projects of the year 2019 of the Government of Navarra. Years of execution 2019-2020. Cooperative together with Hospital Complex of Navarra / Miguel Servet Public Foundation and the Public University of Navarra.
Investigation of the role of microbiota variability in the development and diagnosis of pediatric celiac disease.
Aid for the realization of R & D projects of the year 2018 of the Government of Navarra. Years of execution 2018-2019. Cooperative next to the Complejo Hospitalario de Navarra / Miguel Servet Public Foundation.
Implantation of the genomic diagnosis of epilepsy and migraine in Navarra (GENEURONA).
Aid for the realization of strategic R & D projects 2018-2020 of the Government of Navarra (2018). Years of execution 2018-2020. Cooperating with the University of Navarra, the Foundation for Applied Medical Research and the University Clinic of Navarra.
Industrial research for the study and evaluation of a new biosensor device capable of identifying miRNAs associated with inflammatory diseases mediated by autoimmune mechanisms (miRNA-VALUE)
Project of knowledge transfer of the Government of Navarra 2017 and a grant from technologists of the Government of Navarra. Years of execution 2017-2019. Cooperative with the Public University of Navarra.
Experimental development of an epigenetic test to determine the predisposition to develop celiac disease in pediatric subjects genetically predisposed
Knowledge Transfer Project of the Government of Navarra 2016. Year of execution 2016-2018. Cooperative next to the Complejo Hospitalario de Navarra.
Development of a value-added database based on functional genomic experiments for the search of genetic and epigenetic biomarkers
Torres Quevedo of MINECO. Years of execution 2014-2018.